We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$355M
AUM Growth
+$88M
Cap. Flow
-$58.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
58.86%
Holding
966
New
409
Increased
69
Reduced
50
Closed
347
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSR
776
DELISTED
Fisker Inc.
FSR
-942
Closed -$7K
HCMA
777
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
-1,493
Closed -$15K
AYX
778
DELISTED
Alteryx Inc
AYX
-20
Closed -$1K
EAC
779
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
-169,273
Closed -$1.67M
FAZEW
780
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
-49,951
Closed -$27K
SAGA
781
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
-1,500
Closed -$15K
WRAC
782
DELISTED
Williams Rowland Acquisition Corp.
WRAC
-2,400
Closed -$24K
LCA
783
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
-39,201
Closed -$385K
SLAC
784
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
-3,100
Closed -$30K
SHAP
785
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
-1,171
Closed -$12K
ELIQ
786
DELISTED
Electriq Power Holdings, Inc.
ELIQ
-3,067
Closed -$30K
CSTA
787
DELISTED
Constellation Acquisition Corp I
CSTA
-200
Closed -$2K
FTCH
788
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-512
Closed -$4K
FRXB.U
789
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
-50,000
Closed -$492K
TBCP
790
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
-60,374
Closed -$595K
IPVF
791
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
-2,500
Closed -$24K
CFIV
792
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
-12,603
Closed -$125K
ROSE
793
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
-500
Closed -$5K
ICPT
794
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-86
Closed -$1K
ARTE
795
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
-600
Closed -$6K
BOAC
796
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
-1,835
Closed -$18K
ACAQ
797
DELISTED
Athena Consumer Acquisition Corp.
ACAQ
-50,000
Closed -$503K
BTWN
798
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
-500
Closed -$5K
BIOS
799
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
-506
Closed -$5K
SDC
800
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-683
Closed -$1K

Similar funds

Elequin Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Elequin Capital held 966 positions worth $355M, up 33% from $267M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Elequin Capital withdrew a net $58.3M in Q4 2022, closing 347 positions and reducing 50 holdings. Its most notable exit was Stanley Black & Decker, Inc., an estimated $41.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Elequin Capital opened a new position in State Street SPDR Bloomberg Convertible Securities ETF worth $9.9M.

  • Elequin Capital's largest Q4 2022 buy was State Street SPDR Bloomberg Convertible Securities ETF: 153,900 shares worth $9.9M.
  • Elequin Capital added most to Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q4 2022, an estimated $3.26M increase.
  • Elequin Capital's biggest Q4 2022 reduction was South Jersey Industries, Inc. Corporate Units, cutting an estimated $29.4M.
  • Elequin Capital fully exited Stanley Black & Decker, Inc. in Q4 2022, selling an estimated $41.1M.
  • Elequin Capital's ten largest holdings make up 59% of its $355M portfolio in Q4 2022.
  • Elequin Capital opened 409 new positions and closed 347 in Q4 2022.
  • Elequin Capital's portfolio value rose 33% quarter-over-quarter to $355M.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.